The Asian Private Equity & Venture capital Awards 2023

Event 13 November

The Asian Private Equity & Venture capital Awards 2023

Voting is now closed

Each year, we hold our annual awards to recognise private equity's contribution to the growth of Asian businesses. Our judging process has four stages, which combine the expertise of industry veterans with the public vote. All entries go through a rigorous evaluation, ensuring that only the most deserving are shortlisted.

We will announce the winners at the AVCJ Awards Presentation Dinner on 13 November in Four Seasons Hotel, Hong Kong. 

The Shortlist

Fundraising of the Year - Venture Capital

  • Blackbird Ventures Fund V (Blackbird Ventures)
  • Globis Fund VII (Globis Capital Partners)
  • Matrix Partners China VII (Matrix Partners China)
  • Monolith Venture Fund I (Monolith Management)
  • Nexus Ventures VII (Nexus Venture Partners)

Fundraising of the Year - Mid Cap

  • Advantage Partners VII (Advantage Partners)
  • ChrysCapital IX (ChrysCapital Partners)
  • Dymon Asia Private Equity Fund III (Dymon Asia Private Equity)
  • Growtheum Capital Partners SEA Fund I (Growtheum Capital Partners)
  • Pacific Equity Partners Secure Assets Fund II (Pacific Equity Partners)

Fundraising of the Year - Large Cap

  • Primavera Capital Fund IV (Primavera Capital Group)

Deal of the Year - Small Cap

  • David Jones (Anchorage Capital Partners)
  • Endowus (Citi Ventures, EDBI, Lightspeed SEA, MUFG Innovation Partners, Prosus Ventures, SingTel Innov8, UBS Next)
  • Helix Security Services, Quantum Security Services, ZX Security (Quadrant Private Equity)
  • Kream (Altos Ventures, Mirae Asset Capital, Samsung Securities)
  • Privy (KKR, MDI Ventures, GGV Capital, Telkomsel Mitra Inovasi, Okta Ventures, Singtel Innov8)

Deal of the Year - Mid Cap

  • Anhui SV Foods Technology (DCP Capital)
  • Musinsa (KKR, Wellington Management)
  • Sakura Pharmacy Group (NSSK)
  • Straits Orthopaedics (Quadria Capital)
  • Viewpoint (BPEA EQT)

Deal of the Year - Large Cap

  • Bandhan Mutual Funds (ChrysCapital Partners, GIC)
  • iNova Pharmaceuticals (TPG)
  • Osstem Implant (MBK Partners, UCK Partners)
  • Proterial (Bain Capital, Japan Industrial Partners, Japan Industrial Solutions)
  • SK Future Materials (Hahn & Company)

Exit of the Year - IPO

  • CSI Solar (CDH Investments, CICC Capital, Oriza Holdings, SND Ventures Group, Tsinghua Capital)
  • Global Health (Novo Holdings, SBI Holdings, Temasek Holdings, The Carlyle Group)
  • Hesai Technology (Detong Capital, GL Ventures, Lightspeed China Partners, Lightspeed Venture Partners, Pagoda Investment, Qiming Venture Partners, ZhenFund)
  • Mankind Pharma (Capital International, ChrysCapital)
  • Rise Consulting Group (Sunrise Capital)

Exit of the Year - Small Cap

  • Canva (Blackbird Ventures)
  • Japan Drilling (Aspirant Group)
  • Lunit (Legend Capital)
  • Welfare Suzuran (NSSK)
  • Yaruki Switch Group (Advantage Partners)

Exit of the Year - Mid Cap

  • FV Hospital (Quadria Capital)
  • Medit (UCK Partners)
  • Quasar Medical (The Longreach Group)
  • SciClone Pharmaceuticals (CDH Investments)
  • Up Education (Pacific Equity Partners)

Exit of the Year - Large Cap

  • iNova Pharmaceuticals (Pacific Equity Partners, The Carlyle Group)
  • Manipal Health Enterprise (National Investment & Infrastructure Fund, TPG)
  • Sona Comstar (The Blackstone Group)
  • Vistra (BPEA EQT)
  • Works Human Intelligence (Bain Capital)

Firm of the Year - Venture Capital

  • Altos Ventures
  • Blackbird Ventures
  • Globis Capital Partners
  • Nexus Venture Partners
  • Vertex Ventures Southeast Asia & India

Firm of the Year - Mid Cap

  • Allegro Funds
  • Advantage Partners
  • ChrysCapital Partners
  • Dymon Asia Private Equity
  • Pacific Equity Partners

Firm of the Year - Large Cap

  • Advent International
  • Bain Capital
  • The Blackstone Group
  • TPG